An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC)

Kordo Saeed*, Abhijit M. Bal, Ian M. Gould, Michael Z. David, Matthew Dryden, Efthymia Giannitsioti, Karolin Hijazi, Jessica A. Meisner, Silvano Esposito, Francesco Scaglione, Pierre Tattevin, Andreas Voss

*Corresponding author for this work

Research output: Contribution to journalEditorial

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)9-15
Number of pages7
JournalInternational Journal of Antimicrobial Agents
Volume53
Issue number1
DOIs
Publication statusPublished - Jan 2019

Bibliographical note

Funding Information:
KS has received research grants from Pfizer & Thermo Fisher; MZD has served as a consultant for Baxter during the past year and has received a research grant from GSK. All other authors declare no competing interests.

Funding Information:
KS would like to thank Hampshire Hospitals library staff for all their support. None. KS has received research grants from Pfizer & Thermo Fisher; MZD has served as a consultant for Baxter during the past year and has received a research grant from GSK. All other authors declare no competing interests. Not required.

Keywords

  • Infective endocarditis
  • MRSA
  • PVL
  • Panton–Valentine leukocidin
  • Prosthetic valve endocarditis
  • Staphylococcus aureus

Cite this